We evaluated insulin resistance and assessed the effect of gliclazide
on insulin resistance in a patient with diabetes mellitus associated w
ith Turner's syndrome. Insulin-induced glucose metabolism markedly dec
reased compared with 12 healthy subjects. The insulin dose-response cu
rve of this patient shifted to the right and down, and recovered somew
hat after the administration of gliclazide. This patient had exhibited
marked insulin resistance, which seemed to be caused by a defect at t
he receptor and/or post-receptor levels. Gliclazide reduced her insuli
n resistance, which suggests that this agent is suitable for treating
the insulin resistance in diabetic patients with Turner's syndrome.